Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
09.07.24
/
50%
€44.60
Target price
09.07.25
€49.94
Performance (%)
-39.01%
End price
10.07.25
€27.20
Summary
This prediction ended on 10.07.25 with a price of €27.20. The BUY prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc performed very badly with a performance of -39.01%. JPMorgan_Chase___Co_ has a follow-up prediction for Crinetics Pharmaceuticals Inc where he still thinks Crinetics Pharmaceuticals Inc is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 5.240% | 5.240% | 35.393% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at JPMorgan Chase & Co. from $47.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€30.40
24.09.25
24.09.25
€44.06
24.09.26
24.09.26
58.55%
16.01.26
16.01.26
Stopped prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€27.40
20.11.23
20.11.23
€32.04
20.11.24
20.11.24
100.73%
21.11.24
21.11.24